The aim of the study is to measure serum levels of myristic acid in septic patients and to compare them with myristic acid serum levels in patients with Systemic Inflammatory Response Syndrome of non infective etiology in cohort of patients undergoing cardiac surgery. Furthermore, other biomarkers of sepsis are evaluated in comparison with microbiological findings detected either by standard cultures or by molecular biological methods.